Center for the Study of Childhood and Adolescence

Recent papers from Center for the Study of Childhood and Adolescence

1. Population genetic variation characterised through serial independent pool-seq: the Cyprus Genome ProjectScientific Reports · 2026
2. Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe gliomaFrontiers in Oncology · 2026
3. CD2 costimulation strength: A key regulator of T cell function and anti-tumor immunity that is epigenetically regulatediScience · 2025
4. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesisNature Genetics · 2025
5. CD2 expression is co-regulated with stemness- and exhaustion-associated factors in human T cells2025
6. Integration of circulating tumor DNA in biliary tract cancer: the emerging landscapeHepatic Oncology · 2024
7. Polycythemia vera: past, present and futureLeukemia & lymphoma/Leukemia and lymphoma · 2024
8. Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analysesFrontiers in Immunology · 2023
9. Dynamics and spatial organization of Kv1.3 at the immunological synapse of human CD4+ T cellsBiophysical Journal · 2023
10. The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomesJournal of Clinical Investigation · 2023
11. Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trialsLeukemia & lymphoma/Leukemia and lymphoma · 2023
12. Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer modelsSHILAP Revista de lepidopterología · 2022
13. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic InterventionInternational Journal of Molecular Sciences · 2022
14. Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer’s diseaseFrontiers in Immunology · 2022
15. Clinical values of gene alterations as marker of minimal residual disease in non-M3 acute myeloid leukemiaHematology · 2021
16. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung MetastasisAdvanced Science · 2020
17. The rare DNA ligase IV syndrome: A case reportHuman Pathology Case Reports · 2020
18. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLLBlood · 2020
19. The Role of Tumor-Associated Myeloid Cells in Modulating Cancer TherapyFrontiers in Oncology · 2020
20. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunityTheranostics · 2020